{
    "organizations": [],
    "uuid": "452ea9aa22b92b156964fd3418442fcde6937d60",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-nt-pharma-group-co-fy-net-pr/brief-china-nt-pharma-group-co-fy-net-profit-attributable-rmb-165-2-mln-vs-rmb-116-2-mln-idUSFWN1R80Z4",
    "ord_in_thread": 0,
    "title": "BRIEF-China Nt Pharma Group Co ‍Fy Net Profit Attributable RMB 165.2 Mln VS RMB 116.2 Mln​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - China Nt Pharma Group Co Ltd:\n* ‍FY REVENUE RMB604.8 MILLION VERSUS RMB359.6 MILLION * ‍FY NET PROFIT ATTRIBUTABLE RMB165.2 MILLION VERSUS RMB116.2 MILLION​\n* ‍FINAL DIVIDEND OF HK3.5 CENTS PER SHARE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T06:22:00.000+03:00",
    "crawled": "2018-03-27T12:02:39.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "china",
        "nt",
        "pharma",
        "group",
        "co",
        "ltd",
        "revenue",
        "million",
        "versus",
        "million",
        "net",
        "profit",
        "attributable",
        "million",
        "versus",
        "dividend",
        "cent",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}